Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001270645 | SCV001451376 | likely pathogenic | not provided | 2019-09-04 | criteria provided, single submitter | clinical testing | This CNV is a 1.2 Mb deletion of 5q31.2, on chromosome 5, (seq[GRCh37]del(5)(q31.2); chr5:g.137754277_138994590del), of unknown inheritance. This CNV constitutes a loss encompassing 22 genes that has not been reported in controls. Similar CNVs have been reported in two individuals with developmental delay and delayed speech. Kleffman et al. (2012) reported a 0.9 Mb deletion, fully encompassed within this CNV, in a seven-year-old male presenting with mild developmental delay, delayed speech, borderline short stature, postnatal microcephaly, and mild dysmorphic features that included mild microretrognathia. A larger CNV of 1.8 Mb, fully encompassing the CNV of interest, was reported in a one-year old female with delayed speech, developmental delay, abnormal cry and dysmorphic features which included upslanting palpebral fissures and microretrognathia (Mosca et al. 2007). Based on the available evidence, this CNV is classified as likely pathogenic. |